Takamitsu Fujiu, PhD, JD
Takamitsu Fujiu has served as General Counsel since January 2022, after spending 2021 serving as a legal advisor. Before joining Elixirgen Therapeutics, Inc., Dr. Fujiu worked for the law firm of Morrison & Foerster LLP from 2001 to 2020, where he started as a patent agent and eventually became a partner in the patent group. Before joining the law firm, Dr. Fujiu was a research engineer with focus on material sciences and later became a manager at Nikon Corporation in Japan. Dr. Fujiu holds a Bachelor of Science (Chemistry) from the University of Tokyo, a PhD (Material Sciences) from the Pennsylvania State University and a JD from the Catholic University of America.